# PubMed record PMID 22050344

> PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-22050344-tesamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-22050344-tesamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-22050344-tesamorelin-v1.json
- Content SHA-256: `a07f3ab39a23e44ccbfe532cec4941402661b55500b752b6bc3108e1fda1bb2f`

## Claims and source pins

### Headline

PubMed record PMID 22050344 ([`pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3`](#source-pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3`](#source-pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3`](#source-pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3`](#source-pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3))

## Sources

<a id="source-pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3"></a>
- **PubMed record PMID 22050344 · retained source version 1:2017-11-16:current:bbbbcfcbe5d3029d9911e34a9a33d83c2e07e3368e93beb97d76a7179e85dda0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/22050344/) (`pubmed-observation-pmid-22050344-2017-11-16-bbbbcfcbe5d3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 22050344." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-22050344-tesamorelin-v1.json SHA-256: a07f3ab39a23e44ccbfe532cec4941402661b55500b752b6bc3108e1fda1bb2f.